Psychedelics are back and they offer transformation in a world that desperately needs it.
Current research with psychedelics is yielding promising results in the treatment of trauma, end of life anxiety, depression and addiction. This wave of resurgence has not come about by chance. At the heart of this psychedelic renaissance is a solid foundation of rigorous scientific studies on these substances and MAPS Canada is the organization that has been spearheading a lot of this important work in Canada.
Currently, MAPS Canada has been supporting studies to legalize MDMA-assisted psychotherapy for the treatment of post-traumatic stress disorders which are now entering into the final phases of clinical trials.
Hear more from Mark Haden, Executive Director of MAPS Canada about the exciting and transformative future of psychedelic treatments in the video above.